Journal of the International AIDS Society

Article	Citations
Weight gain before and after switch from TDF to TAF in a U.S. cohort study	79
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub‐Saharan Africa: a rapid systematic review	78
Increasing awareness of HIV pre‐exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta‐analysis of global data	73
Acceleration of differentiated service delivery for HIV treatment in sub‐Saharan Africa during COVID‐19	64
New pathogen, same disparities: why COVID‐19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic	54
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial	52
Weight gain during the dolutegravir transition in the African Cohort Study	49
Treating depression and improving adherence in HIV care with task‐shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial	49
Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial	47
Prevalence and factors associated with common mental disorders in young people living with HIV in sub‐Saharan Africa: a systematic review	47
Current approaches to HIV vaccine development: a narrative review	47
Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa	44
Antiretroviral treatment interruption among people living with HIV during COVID‐19 outbreak in China: a nationwide cross‐sectional study	41
PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project	39
Estimating the contribution of key populations towards HIV transmission in South Africa	39
The impact of COVID‐19 on multi‐month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR‐supported countries: a multi‐country analysis	38
Declining HIV incidence in sub‐Saharan Africa: a systematic review and meta‐analysis of empiric data	36
Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa	36
Interventions to address the mental health of adolescents and young adults living with or affected by HIV: state of the evidence	35
Project Khanya: results from a pilot randomized type 1 hybrid effectiveness‐implementation trial of a peer‐delivered behavioural intervention for ART adherence and substance use in HIV care in South A	35
Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta‐analysis	32
Understanding disparities in viral suppression among Black MSM living with HIV in Atlanta Georgia	31
Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub‐Saharan Africa	30
Updates to the Spectrum/AIM model for the UNAIDS 2020 HIV estimates	29
The impact of the COVID‐19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review	29

Mental health interventions for persons living with HIV in low‐ and middle‐income countries: a systematic review	29
Pathways for reduction of HIV‐related stigma: a model derived from longitudinal qualitative research in Kenya and Uganda	29
Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review	28
A call to improve understanding of Undetectable equals Untransmittable (U = U) in Brazil: a web‐based survey	28
Attrition in HIV care following HIV diagnosis: a comparison of the pre‐UTT and UTT eras in South Africa	28
Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta‐analysis	28
Overview of the epidemiological conditions of HIV among key populations in Africa	28
HIV self‐testing partially filled the HIV testing gap among men who have sex with men in China during the COVID‐19 pandemic: results from an online survey	28
Men missing from the HIV care continuum in sub‐Saharan Africa: a meta‐analysis and meta‐synthesis	27
“It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid‐19	27
“I just keep quiet about it and act as if everything is alright” – The cascade from trauma to disengagement among adolescents living with HIV in western Kenya	27
Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study	27
Two years after lockdown: reviewing the effects of COVID‐19 on health services and support for adolescents living with HIV in South Africa	26
Prevalence of nonsuppressed viral load and associated factors among HIV‐positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from	26
Twenty‐four‐month outcomes from a cluster‐randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs	26
A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya	26
Missed opportunities for sexually transmitted infections testing for HIV pre‐exposure prophylaxis users: a systematic review	25
Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients	25
Youth engagement in HIV prevention intervention research in sub‐Saharan Africa: a scoping review	25
The impact of disruptions due to COVID‐19 on HIV transmission and control among men who have sex with men in China	24
Intervening for HIV prevention and mental health: a review of global literature	24
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies	24
HIV prevention: better choice for better coverage	24
Preference for daily versus on‐demand pre‐exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real‐world Oral PrEP Demonstration study	24
Intimate partner and client‐perpetrated violence are associated with reduced HIV pre‐exposure prophylaxis (PrEP) uptake, depression and generalized anxiety in a cross‐sectional study of female sex wor	23
Preference for using a variety of future HIV pre‐exposure prophylaxis products among men who have sex with men in three US cities	23
Home‐Based Intervention to Test and Start (HITS): a community‐randomized controlled trial to increase HIV testing uptake among men in rural South Africa	22
What can we learn from HIV, COVID‐19 and mpox stigma to guide stigma‐informed pandemic preparedness?	22
HIV self‐testing and oral pre‐exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda	22
Intersecting stigma and HIV testing practices among urban refugee adolescents and youth in Kampala, Uganda: qualitative findings	22
Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub‐Saharan Africa	22
Uncovering ART adherence inconsistencies: An assessment of sustained adherence among adolescents in South Africa	22
Adherence to event‐driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3‐monthly questionnaires and intracellular TFV‐DP	22
Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness st	22
Key populations are the future of the African HIV/AIDS pandemic	22
Broadly neutralizing monoclonal antibodies for HIV prevention	22
Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial	22
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study	21
Healthcare worker training to improve quality of care for sexual and gender minority people in sub‐Saharan Africa: learning from efforts in Uganda	21
Imperfect adherence in real life: a prevention‐effective perspective on adherence to daily and event‐driven HIV pre‐exposure prophylaxis among men who have sex with men – a prospective cohort study in	21
Community‐based differentiated service delivery models incorporating multi‐month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits:	20
Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study	20
Effects of behavioural interventions on postpartum retention and adherence among women with HIV on lifelong ART: the results of a cluster randomized trial in Kenya (the MOTIVATE trial)	20
Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID‐19 pandemic: descriptive analysis of programmatic data	20
Using a mixed‐methods approach to adapt an HIV stigma reduction intervention to address intersectional stigma faced by men who have sex with men in Ghana	20
Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project	20
HIV service delivery in the time of COVID‐19: focus group discussions with key populations in India	19
Progress towards 2020 global HIV impact and treatment targets	19
HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs	19
Inclusion as illusion: erasing transgender women in research with MSM	19

Frameworks and measures for HIV‐related internalized stigma, stigma and discrimination in healthcare and in laws and policies: a systematic review	19
The question of the question: impactful implementation science to address the HIV epidemic	18
Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice	18
Characteristics of the HIV cascade of care and unsuppressed viral load among gay, bisexual and other men who have sex with men living with HIV across Canada’s three largest cities	18
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study	18
The HIV care cascade in sub‐Saharan Africa: systematic review of published criteria and definitions	18
Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort	18
Global scoping review of HIV prevention research with transgender people: Transcending from trans‐subsumed to trans‐centred research	17
Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three‐arm cluster randomized controlled trial	17
Does resource insecurity drive HIV‐related stigma? Associations between food and housing insecurity with HIV‐related stigma in cohort of women living with HIV in Canada	17
Adopting U = U to end stigma and discrimination	17
A one‐stop shop model for improved efficiency of pre‐exposure prophylaxis delivery in public clinics in western Kenya: a mixed methods implementation science study	17
Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled	17
Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium	17
Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study	16
Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (CUSTOMIZE)	16
“You are not a man”: a multi‐method study of trans stigma and risk of HIV and sexually transmitted infections among trans men in Uganda	16
Evidence of an untamed HIV epidemic among MSM and TGW in Rio de Janeiro, Brazil: a 2018 to 2020 cross‐sectional study using recent infection testing	16
Choosing event‐driven and daily HIV pre‐exposure prophylaxis – data from two European PrEP demonstration projects among men who have sex with men	16
HIV PrEP is more than ART‐lite: Longitudinal study of real‐world PrEP services data identifies missing measures meaningful to HIV prevention programming	16
Acceptability and feasibility of leveraging community‐based HIV counselling and testing platforms for same‐day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa	16
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States	16
Point‐of‐care testing can achieve same‐day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries	16
High rates of long‐term progression in HIV‐1‐positive elite controllers	15
Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV	15
Health‐related needs reported by adolescents living with HIV and receiving antiretroviral therapy in sub‐Saharan Africa: a systematic literature review	15
Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda	15
Development and validation of the HIV adolescent readiness for transition scale (HARTS) in South Africa	14
Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis	14
What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis	14
Prevalence of and factors associated with advanced HIV disease among newly diagnosed people living with HIV in Guangdong Province, China	14
Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana	14
Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study	14
Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain	14
The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru	14
Integrating mental health into HIV prevention and care: a call to action	14
Progress towards the UNAIDS 90‐90‐90 targets among persons aged 50 and older living with HIV in 13 African countries	14
Evaluation of near point‐of‐care viral load implementation in public health facilities across seven countries in sub‐Saharan Africa	14
Engagement in the pre‐exposure prophylaxis (PrEP) cascade among a respondent‐driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbab	14
A qualitative study of how stigma influences HIV services for transgender men and women in Nigeria	13
Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID‐19	13
The efficacy and cost‐effectiveness of a family‐based economic empowerment intervention (Suubi + Adherence) on suppression of HIV viral loads among adolescents living with HIV: results from a Cluster	13
Uptake of Primary Care Services and HIV and Syphilis Infection among Transgender Women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016 – 2019	13
Comparison between daily and on‐demand PrEP (pre‐exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open‐label,	13
Examining the relationship between physical and sexual violence and psychosocial health in young people living with HIV in rural South Africa	13
Risk scores for predicting HIV incidence among adult heterosexual populations in sub‐Saharan Africa: a systematic review and meta‐analysis	13
Sexual behaviour change following HIV testing services: a systematic review and meta‐analysis	13
Willingness to use and preferences for long‐acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021–2022: cross‐sectional study	13
PrEP user profiles, dynamics of PrEP use and follow‐up: a cohort analysis at a Belgian HIV centre (2017–2020)	13
A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV‐negative women planning for or with pregnancy in rural Southwestern Uganda	12
Risk factors for HIV virological non‐suppression among adolescents with common mental disorder symptoms in Zimbabwe: a cross‐sectional study	12
HIV prevalence among men who have sex with men, transgender women and cisgender male sex workers in sub‐Saharan Africa: a systematic review and meta‐analysis	12
How community ART delivery may improve HIV treatment outcomes: Qualitative inquiry into mechanisms of effect in a randomized trial of community‐based ART initiation, monitoring and re‐supply (DO ART)	12
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent	12
Impact of the COVID‐19 pandemic on HIV prevention and care services among key populations across 15 cities in India: a longitudinal assessment of clinic‐based data	12
Using the adherence‐efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background HIV incidence: a secondary analysis of a randomized, controlled trial	12
Improving retention in antenatal and postnatal care: a systematic review of evidence to inform strategies for adolescents and young women living with HIV	12
Individual health behaviours to combat the COVID‐19 pandemic: lessons from HIV socio‐behavioural science	12
Adequate funding of comprehensive community‐based programs for key populations needed now more than ever to reach and sustain HIV targets	12
Evaluation of the integration of telehealth into the same‐day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID‐19: a mixed‐method analysis of real‐world data	12
An evaluation of assumptions underlying respondent‐driven sampling and the social contexts of sexual and gender minority youth participating in HIV clinical trials in the United States	12
Integration of mental health services into HIV healthcare facilities among Thai adolescents and young adults living with HIV	12
It is a question of equity: time to talk about children who are HIV‐exposed and “HIV‐free”	12
Peer community health workers improve HIV testing and ART linkage among key populations in Zambia: retrospective observational results from the Z‐CHECK project, 2019–2020	11
High prevalence of anal high‐risk HPV infection among transwomen: estimates from a Brazilian RDS study	11
Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa	11
Tissue‐specific differences in HIV DNA levels and mechanisms that govern HIV transcription in blood, gut, genital tract and liver in ART‐treated women	11
Cognitive outcomes at ages seven and nine years in South African children from the children with HIV early antiretroviral (CHER) trial: a longitudinal investigation	11
When healthcare providers are supportive, ‘I'd rather not test alone’: Exploring uptake and acceptability of HIV self‐testing for youth in Zimbabwe – A mixed method study	11
Association between HIV PrEP indications and use in a national sexual network study of US men who have sex with men	11
HIV‐sensitive social protection for vulnerable young women in East and Southern Africa: a systematic review	11
Predictors of mortality among adolescents and young adults living with HIV on antiretroviral therapy in Dar es Salaam, Tanzania: a retrospective cohort study	11
Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1	11
Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study	11
The longitudinal association between depression, anxiety symptoms and HIV outcomes, and the modifying effect of alcohol dependence among ART clients with hazardous alcohol use in Vietnam	11
4th HIV Research for Prevention conference (HIVR4P // Virtual), 27 & 28 January | 3 & 4 February 2021	11
Silver linings: how COVID‐19 expedited differentiated service delivery for HIV	11
Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide	11
Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action	11
Advancing the use of Long‐Acting Extended Delivery formulations for HIV prevention in sub‐Saharan Africa: challenges, opportunities, and recommendations	11

Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework	10
Use of quality‐of‐life instruments for people living with HIV: a global systematic review and meta‐analysis	10
Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID‐19 pandemic in China: a qualitative study	10
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort)	10
Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics	10
Outcomes from a multimodal, at‐scale community‐based HIV counselling and testing programme in twelve high HIV burden districts in South Africa	10
Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrosp	10
Distribution of antiretroviral therapy through private pharmacies and postal courier services during COVID‐19 in Botswana: acceptability and reach of two out‐of‐facility individual differentiated serv	10
The promise of paediatric dolutegravir	10
Tuberculosis treatment within differentiated service delivery models in global HIV/TB programming	10
Estimating the epidemic consequences of HIV prevention gaps among key populations	10
Prevention challenges with current perceptions of HIV burden among HIV‐negative and never‐tested men who have sex with men in the Netherlands: a mixed‐methods study	10
Measuring patient engagement with HIV care in sub‐Saharan Africa: a scoping study	10
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL	10
Intersecting HIV and mpox epidemics: more questions than answers	10
Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population‐based survey data	10
Mobility and HIV care engagement: a research agenda	10
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis	9
Uptake of community‐ versus clinic‐based antiretroviral therapy dispensing in the Central Chronic Medication Dispensing and Distribution program in South Africa	9
Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: A mixed‐methods study	9
Acceptability and satisfaction towards self‐collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal	9
Ten‐year attrition and antiretroviral therapy response among HIV‐positive adults: a sex‐based cohort analysis from eight West African countries	9
“I was still very young”: agency, stigma and HIV care strategies at school, baseline results of a qualitative study among youth in rural Kenya and Uganda	9
Retention in care and viral suppression after same‐day ART initiation: One‐year outcomes of the SLATE I and II individually randomized clinical trials in South Africa	9
Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review	9
Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa	9
Subtype‐specific differences in transmission cluster dynamics of HIV‐1 B and CRF01_AE in New South Wales, Australia	9
The impact of prevention‐effective PrEP use on HIV incidence: a mathematical modelling study	9
Preferences and acceptability for long‐acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya	9
Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition	9
Approaches to accelerating the study of new antiretrovirals in pregnancy	9
Mental health and initiation of antiretroviral treatment at enrolment into HIV care in Cameroon under a national “treat all” policy: a cross‐sectional analysis	9
Changes in HIV treatment differentiated care uptake during the COVID‐19 pandemic in Zambia: interrupted time series analysis	9
Prevalence of cardiovascular risk factors by HIV status in a population‐based cohort in South Central Uganda: a cross‐sectional survey	9
Examining provincial PrEP coverage and characterizing PrEP awareness and use among gay, bisexual and other men who have sex with men in Vancouver, Toronto and Montreal, 2017–2020	9
The likelihood of severe COVID‐19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta‐analysis approach	9
Providing differentiated service delivery to the ageing population of people living with HIV	9
Addressing epistemic injustice in HIV research: a call for reporting guidelines on meaningful community engagement	9
HIV testing and linkage to ART following secondary distribution of HIV self‐test kits to male partners of women living with HIV: a pilot randomized control trial in Mpumalanga, South Africa	9
Ending TB: the world’s oldest pandemic	9
Incremental costs of integrated PrEP provision and effective use counselling in community‐based platforms for adolescent girls and young women in South Africa: an observational study	9
Uncovering the NAFLD burden in people living with HIV from high‐ and middle‐income nations: a meta‐analysis with a data gap from Subsaharan Africa	9
Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Eval	9
Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy	9